What is xience xpedition stent?
The Xience Xpedition stent is indicated for patients with symptomatic heart disease due to de novo native coronary artery lesions with reference vessel diameters of 2.25 mm to 4.25 mm. In addition to the United States, the stent is available in the Europe, the Middle East and parts of Asia.
What is a Xience everolimus eluting coronary stent?
The XIENCE family of Everolimus Eluting Coronary Stent Systems (XIENCE Alpine EECSS, XIENCE Sierra EECSS, XIENCE Skypoint EECSS) is intended to treat a narrowed blood vessel (coronary artery) caused by coronary artery disease. Each system consists of a cobalt chromium alloy metal stent and a catheter delivery system.
What is the best drug eluting stent?
Nobori – The top drug-eluting stents.
What is price of Xience Xpedition cardiac stent?
Stent pricing
DRUG ELUTING STENTS | ||
---|---|---|
BRAND | MANUFACTURER | Ceiling Price with GST |
XIENCE XPEDITION | ABBOTT VASCULAR | 32,351.00 |
XIENCE PRIME | ABBOTT VASCULAR | 32,351.00 |
XIENCE V | ABBOTT VASCULAR | 23,625.00 |
How long should you be on blood thinners after a stent?
Guidelines now call for most patients to take aspirin and blood thinner for more than a year and as long as 30 months to prevent blood clots from forming in their stent, Butala said.
How long do drug-eluting stents last?
Our study findings suggest that the long-term survival (to 3 years) of patients with drug-eluting stents remains favourable overall. It is not measurably worse than that of patients with bare-metal stents.
Which stent is best for heart?
A drug-eluting stent is the most common type of stent used to treat a blockage of the heart arteries. Many people with heart problems have been successfully treated with drug-eluting stents, preventing the need for more-invasive procedures, such as coronary artery bypass surgery.
What is a xience Sierra stent?
The XIENCE Sierra stent system is indicated for improving coronary artery luminal diameter in patients, including those with diabetes mellitus, with symptomatic heart disease due to de novo native coronary artery lesions (length £ 32 mm) with reference vessel diameters of ≥ 2.25 mm to ≤ 4.25 mm.